Does Therapy with Glucagon-like Peptide 1 Receptor Agonists Have an Effect on Biochemical Markers of Metabolic-Dysfunction-Associated Steatotic Liver Disease (MASLD)? Pleiotropic Metabolic Effect of Novel Antidiabetic Drugs in Patients with Diabetes—Interventional Study

Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) is associated with the excessive collection of lipids in hepatocytes. Over 75% of diabetes patients typically have MASLD, and, at the same time, the presence of MASLD increases the risk of diabetes by more than two times. Type 2 diabet...

Descripción completa

Detalles Bibliográficos
Autores principales: Hachuła, Marcin, Kosowski, Michał, Basiak, Marcin, Okopień, Bogusław
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534491/
https://www.ncbi.nlm.nih.gov/pubmed/37764998
http://dx.doi.org/10.3390/ph16091190

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10534491/
https://www.ncbi.nlm.nih.gov/pubmed/37764998
http://dx.doi.org/10.3390/ph16091190

Ejemplares similares